Discover 1,294 paid clinical trials in Chandler, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
for
Ovarian Cancer
Location: Phoenix AZ, Rochester MN, Charleston WV, Cleveland OH,
Sponsor: NX Development Corp
Sex: Female
Age: 18+
Code: NCT05804370
Phase 3, Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Phoenix AZ, Irvine CA, Fountain Valley CA,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Phoenix AZ, St Louis MO, Rochester MN, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07393282
Phase 3, Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
for
Cervical Squamous Cell Carcinoma,
Location: Phoenix AZ, Los Angeles CA, San Antonio TX, Houston TX,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT07169734
Phase 1, Phase 2, Recruiting
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
for
Pancreatic Cancer
Location: Phoenix AZ, Houston TX, Charlottesville VA, Hartford CT,
Sponsor: Craig L Slingluff, Jr
Sex: All
Age: 18+
Code: NCT02305186
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Avondale AZ, Tucson AZ, Salt Lake City UT, Plano TX,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase 1, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Phoenix AZ, Tucson AZ, Los Angeles CA, Oklahoma City OK,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase 1, Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
for
Sickle Cell Disease
Location: Phoenix AZ, Los Angeles CA, Clovis CA, Houston TX,
Sponsor: Sanofi
Sex: All
Age: 10 - 65
Code: NCT06975865
Phase 3, Recruiting
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial